CINECA IRIS Institutional Research Information System

CIAMPORCERO, ERIC STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.170
EU - Europa 1.131
AS - Asia 831
SA - Sud America 33
AF - Africa 17
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.199
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.135
CN - Cina 474
IT - Italia 388
SE - Svezia 121
IE - Irlanda 92
JP - Giappone 81
DE - Germania 78
SG - Singapore 69
FR - Francia 64
FI - Finlandia 52
GB - Regno Unito 52
PL - Polonia 51
AT - Austria 42
KR - Corea 42
DK - Danimarca 33
TW - Taiwan 32
UA - Ucraina 28
VN - Vietnam 26
CA - Canada 24
HK - Hong Kong 24
ID - Indonesia 24
ES - Italia 23
IN - India 23
BR - Brasile 22
NL - Olanda 20
BE - Belgio 18
AU - Australia 14
RU - Federazione Russa 13
MX - Messico 10
HR - Croazia 8
TH - Thailandia 8
SN - Senegal 7
CZ - Repubblica Ceca 6
GR - Grecia 6
HU - Ungheria 6
RO - Romania 6
TR - Turchia 6
BG - Bulgaria 5
CO - Colombia 5
PT - Portogallo 5
CH - Svizzera 4
EG - Egitto 4
IR - Iran 4
MY - Malesia 4
BY - Bielorussia 3
EU - Europa 3
IL - Israele 3
RS - Serbia 3
UZ - Uzbekistan 3
CL - Cile 2
ET - Etiopia 2
NG - Nigeria 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BT - Bhutan 1
KE - Kenya 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
PK - Pakistan 1
QA - Qatar 1
UY - Uruguay 1
ZM - Zambia 1
Totale 4.199
Salva come PNG Salva come JPEG
Città #
Fairfield 207
Chandler 175
Torino 174
Beijing 137
Ashburn 128
Houston 128
Woodbridge 103
Ann Arbor 95
Dublin 91
Seattle 81
Redwood City 76
Wilmington 76
Cambridge 73
Singapore 58
Jacksonville 57
Pisa 56
Shanghai 54
Nyköping 45
Dearborn 42
Villeurbanne 42
Vienna 40
Warsaw 35
Nanjing 32
Fremont 31
Princeton 29
Guangzhou 25
Medford 25
New York 24
Taipei 23
Chengdu 20
Changsha 16
Shenyang 16
Boardman 15
Jakarta 15
Los Angeles 15
Dong Ket 14
Hangzhou 14
San Diego 14
Washington 13
Silver Spring 12
Brussels 11
Jinan 11
Milan 11
Tianjin 11
Tokyo 11
Turin 11
Boston 10
Phoenix 9
London 8
Napoli 8
Wuhan 8
Hefei 7
Helsinki 7
Montréal 7
Zhengzhou 7
Berlin 6
Hong Kong 6
Nanchang 6
Polska 6
Renton 6
Rome 6
Santa Clara 6
Seoul 6
São Paulo 6
Bangkok 5
Barcelona 5
Chicago 5
Moscow 5
Newcastle 5
Norwalk 5
Okayama 5
Ripon 5
Xian 5
Baltimore 4
Bogotá 4
Central District 4
Changzhou 4
Düsseldorf 4
Harbin 4
Hebei 4
Mansfield 4
Molise 4
Munich 4
Novosibirsk 4
Philadelphia 4
Piscataway 4
San Marcos 4
South Dennis 4
Toronto 4
Tucson 4
Valencia 4
Ahmedabad 3
Belgrade 3
Bloomfield 3
Charleston 3
Chongqing 3
Columbia 3
Detmold 3
Duncan 3
Eschweiler 3
Totale 2.661
Salva come PNG Salva come JPEG
Nome #
Role of 4-Hydroxynonenal-Protein Adducts in Human Diseases. 865
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer 627
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses 324
Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models. 242
Drug Delivery Nanoparticles in Skin Cancers 221
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of Β-cyclodextrin enhances the antitumoralefficacyof the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model 200
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage 196
AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile, in CaCo-2 colon cancer cells. 166
Interaction of aldehydes derived from lipid peroxidation and membrane proteins. 162
Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells 158
Generation of Adducts of 4-Hydroxy-2-nonenal with Heat Shock 60 kDa Protein 1 in Human Promyelocytic HL-60 and Monocytic THP-1 Cell Lines 146
In Vitro Modeling of Tissue-Specific 3D Microenvironments and Possibile Application to Pediatric Cancer Research 139
PPARy in coronary atherosclerosis: In vivo expression pattern and correlations with hyperlipidemic status and statin treatment 126
Lipid peroxidation in colorectal carcinogenesis: bad and good news 118
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 94
Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells. 89
Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells. 80
Hippo pathway effector Yes-associated protein and cisplatin resistance in transitional cell carcinoma of the bladder 70
Targeting Cell Cycle Through Combination of the Histone Deacetylase Inhibitor, LBH589,and Lipids Peroxidation End Product,4-Hydroxnonenal (HNE), in PC3 Prostate Cancer Cells. 67
Rosiglitazone and AS601245 Decrease Cell Adhesion and Migartion Trhougt modulation of specific Gene Expression in Human Colon Cancer Cells. 65
GSH-responsive nanoparticles in the treatment of tumor cells. 64
Combined Antitumoral Efficacy of the Histone Deacetilase Inhibitor LBH589 and Lipids Peroxidation End Product 4-Hydroxinonenal(HNE)on PC3 Prostate Cancer Cell. 63
Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition 49
Totale 4.331
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.923
article - articoli 0
book - libri 0
conference - conferenze 799
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.722
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020706 0 0 47 93 61 112 89 83 78 60 41 42
2020/2021621 40 37 44 49 55 34 62 48 65 56 71 60
2021/2022444 24 30 24 35 19 25 22 17 24 50 112 62
2022/2023526 59 48 11 59 48 140 31 13 44 23 23 27
2023/2024371 33 56 34 23 17 50 16 39 4 23 39 37
2024/2025108 14 50 44 0 0 0 0 0 0 0 0 0
Totale 4.331